Labiotech.eu

pure biologics wroclaw devics disease 1 1

Startup Scout 31 May 2019

This Biotech Treats a Neurological Autoimmune Disorder Using DNA

We’re jumping into Poland this week. Pure Biologics is a biotech based in Wrocław developing DNA molecules that could treat the incurable neurological condition Devic’s disease with fewer side effects than existing treatments. Mission: To develop a treatment that makes an existing treatment for Devic’s disease, plasmapheresis, more targeted and with fewer side effects than […]

May 31, 2019 - 4 minutesmins - By Jonathan Smith

Interview 30 May 2019

Taking Inspiration from Plants to Prevent Mold from Ruining Crops

Olga Dubey founded the Swiss startup Agrosustain with the intention to bring forth a natural alternative to chemical pesticides against mold. She shares how it all started and her company’s plans to end the massive amounts of food waste that mold is responsible for. “Mold is everywhere, so it’s something that is very hard to […]

May 30, 2019 - 4 minutesmins - By Clara Rodríguez Fernández

gensight gene therapy lhon genetic blindness

News and Trends 29 May 2019

After Unexpected Setback, GenSight Seeks Approval for Blindness Gene Therapy

The French biotech GenSight will apply for regulatory approval for its gene therapy despite the treatment unexpectedly resulting in the improvement of the eyes treated with a placebo in a phase III trial. GenSight is developing a gene therapy designed to treat progressive vision loss caused by the rare genetic condition Leber hereditary optic neuropathy. […]

May 29, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 29 May 2019

€60M Investment to Boost Oxford Biomedica’s Gene and Cell Therapies

The Danish investor Novo Holdings is handing Oxford Biomedica up to €60.6M (£53.5M) to develop gene and cell therapies treating cancer and genetic blindness. The investment will bag Novo Holdings a stake of up to 10.1% in the UK biotech. Oxford Biomedica will use the money to repay a loan totalling €49M ($55M) from the […]

May 29, 2019 - 2 minutesmins - By Jonathan Smith

nanobiotix nanotechnology nanoparticle cancer

More News! 28 May 2019

Nanomedicine Company Launches in France to Improve Drug Safety

The French nanomedicine biotech Nanobiotix is spinning out a subsidiary company developing nanoparticles that can enhance a drug’s effectiveness and decrease side effects. Called Curadigm, the spinout will be developing nanotechnology with the potential to make low drug doses more effective at treating different conditions, which could make treatments cheaper and with fewer side effects […]

May 28, 2019 - 2 minutesmins - By Jonathan Smith

Interview 28 May 2019

Getting Ahead of the Pack in the CAR-T Field

Celyad is one of many companies in the immuno-oncology field seeking to take the lead in the development of a new generation of CAR-T cell therapy that outperforms its predecessors Yescarta and Kymriah in both efficacy and safety. Filippo Petti, CEO of Celyad, shares the company’s strategy to get ahead in such a crowded field. […]

May 28, 2019 - 6 minutesmins - By Clara Rodríguez Fernández

small respiratory syncytial virus alzheimers disease sweden 1

News and Trends 28 May 2019

Viral Vaccines Could Be Weapons Against Alzheimer’s Disease

Scientists in Sweden have found that some viruses can increase the buildup of protein ‘plaques’ linked to Alzheimer’s disease, a discovery that could lead to new vaccines treating the condition. According to Kariem Ezzat, one of the lead researchers based in Stockholm University, the group is looking for industrial collaborators to develop vaccines against viruses […]

May 28, 2019 - 3 minutesmins - By Jonathan Smith

More News! 24 May 2019

French Pharma Acquires Israeli Microalgae Biotech

The French pharmaceutical manufacturer Solabia has acquired the Israeli biotech Algatech, which grows microalgae to produce bio-sourced food additives. The financial details of the acquisition were undisclosed. The incoming financial backing from Solabia will fuel the expansion of Algatech’s manufacturing muscle and research programs, which are based in the deserts of Israel. The acquisition represents […]

May 24, 2019 - 2 minutesmins - By Jonathan Smith

Startup Scout 24 May 2019

This Biotech Uses Gene Editing to Count Chickens Before They Hatch

In the city of Jerusalem, eggXYt is developing gene edited chickens whose male chicks fluoresce inside the egg. This could prevent the suffering of billions of male chicks in the egg-production industry, which are currently culled after hatching. Mission: To develop a gene edited breed of chickens whose sex can be determined before hatching using […]

May 24, 2019 - 3 minutesmins - By Jonathan Smith

More News! 23 May 2019

Irish Life Sciences VC Raises €118M Fund with European Focus

Fountain Healthcare Partners has raised €118M in its third fund dedicated to investing in life sciences, with the majority of the funds destined to go to European companies. Of the total raised, €45M was contributed by the European Investment Fund, which invested in both of Fountain’s previous funds. Other investors are Coolidge Limited, the Ireland […]

May 23, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 23 May 2019

Why Clinical Trial Design Can Make or Break Your Company

Andreas Wallnöfer spent over 20 years working on drug development at Roche before moving to BioMedPartners to apply his expertise to biotech investment. At our recent Labiotech Refresh event in Zurich, he explained why good clinical trial design can be key to a biotech’s success. Wallnöfer was one of the pioneers of ‘proof of concept’ […]

May 23, 2019 - 7 minutesmins - By Helen Albert

Inside Labiotech 23 May 2019

See you Labiotech, it has been an awesome ride 🚀

It’s with a lot of emotion that I’m announcing this news today. I will step down as CEO of Labiotech, while my co-founder Joachim will lead the company forward. At the end of June, I will step down, and then remain a shareholder and on the board of the company to keep supporting the team […]

May 23, 2019 - 4 minutesmins - By Philip Hemme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

This Biotech Treats a Neurological Autoimmune Disorder Using DNA

Taking Inspiration from Plants to Prevent Mold from Ruining Crops

After Unexpected Setback, GenSight Seeks Approval for Blindness Gene Therapy

€60M Investment to Boost Oxford Biomedica’s Gene and Cell Therapies

Nanomedicine Company Launches in France to Improve Drug Safety

Getting Ahead of the Pack in the CAR-T Field

Viral Vaccines Could Be Weapons Against Alzheimer’s Disease

French Pharma Acquires Israeli Microalgae Biotech

This Biotech Uses Gene Editing to Count Chickens Before They Hatch

Irish Life Sciences VC Raises €118M Fund with European Focus

Why Clinical Trial Design Can Make or Break Your Company

See you Labiotech, it has been an awesome ride 🚀

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!